Cipla Ltd, a Mumbai based third largest pharma company in India, has posted better performance during the quarter ended December 2007 despite strong rupee in terms of US dollar. The company\'s net profit increased by 14 2 per cent to Rs 210.65 crore from Rs 184.38 crore in the corresponding period of last year. Its net sales increased by 25.4 per cent to Rs 1104 crore from Rs 881 crore. The earning per share went up to Rs 2.71 from Rs 2.37 in the last period.

Its domestic sales increased by 19.3 per cent during the quarter under review to Rs 519.51 crore from Rs 435.30 crore and its Exports surged by 22.3 per cent to Rs 510.92 crore from Rs 417.87 crore. Exports as per cent of net sales improved to 49.6 per cent from 49 per cent in the similar quarter of last year.

For the nine months period, Cipla has achieved net sales of Rs 3105 crore as against Rs 2634 crore in the first nine months of last year, a growth of 17.9 per cent. However, its net profit declined by 2.6 per cent to Rs 521 crore from Rs 535 crore. The profit before interest, depreciation and taxation also declined by 1.5 per cent to Rs 732 crore from Rs 743 crore. The company\'s exports during the nine months ended December 2007 improved by 16.7 per cent to Rs 1,460 crore from Rs 1,251 crore in the last period.